Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA

Adv Neurol. 1996:69:487-91.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / administration & dosage*
  • Antiparkinson Agents / therapeutic use*
  • Carbidopa / administration & dosage*
  • Carbidopa / therapeutic use*
  • Delayed-Action Preparations
  • Drug Combinations
  • Female
  • Humans
  • Levodopa / administration & dosage*
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Delayed-Action Preparations
  • Drug Combinations
  • Levodopa
  • Carbidopa